Filing Details
- Accession Number:
- 0001209191-20-046134
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-11 16:34:22
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-11 16:34:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1621334 | Pat Cotroneo | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Svp, Finance And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-07 | 22,554 | $19.39 | 293,614 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-08-07 | 22,554 | $48.00 | 271,060 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-08-11 | 3,750 | $19.39 | 274,810 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-08-11 | 3,500 | $18.00 | 278,310 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-07 | 22,554 | $0.00 | 22,554 | $19.39 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-11 | 3,750 | $0.00 | 3,750 | $19.39 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-08-11 | 3,500 | $0.00 | 3,500 | $18.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,446 | 2026-02-22 | No | 4 | M | Direct | |
5,696 | 2026-02-22 | No | 4 | M | Direct | |
0 | 2024-11-13 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- Fully vested.